Table 3

Immunological parameters: difference between treatment group (aVQ) and control group by independentt-test and result of the repeated measured analysis of variance (ANOVA, influence of treatment)
Values at baseline (SD) Difference between aVQ and control
aVQ Control t t t t F
baseline week 8 week 16 week 24 ANOVA
CD 16+/CD 56+ 10.5 (4.16) 9.38 (3.61) −0.816 −0.3458 −0.452 −0.2512 0.2823
CD 19+ 21.06 (13.71) 20.25 (8.97) −0.198 0.2786 0.1885 0.3131 0.0199
TNF-α 2.18 (1.61) 1.6 (0.49) −1.381 −1.4135 −0.407 −1.6893 2.7911
IL-2 1.04 (0.56) 0.94 (0.44) −0.58 −1.0269 −1.34 −1.019 2.1181

SD: standard deviation; CD 16+/CD 56+ : lymphocytes with CD 16+/CD 56+ (NK-cells), CD 19+ : lymphocytes with CD 19+, TNF-α: tumor necrosis factor alpha, IL-2: interleukin-2.

Kim et al.

Kim et al. BMC Complementary and Alternative Medicine 2012 12:172   doi:10.1186/1472-6882-12-172

Open Data